DEBRA HELLMAN: Open Payments
NPI 1689878902 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 15 payments from 6 companies in 2025. Trend: 2023 $307 · 2024 $255 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $148 |
| Regeneron Healthcare Solutions, Inc. | 2 | $117 |
| GlaxoSmithKline, LLC. | 1 | $71 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| United Therapeutics Corporation | 1 | $16 |
Products named: NUCALA, OFEV, TEZSPIRE, GLASSIA, Tyvaso, DUPIXENT, JASCAYD.
Industry payments across ND — which companies pay providers there.
